Horizon Pharma (HZNP) PT Raised to $17 at Cantor Fitzgerald Following 'Beat and Raise'
Tweet Send to a Friend
Cantor Fitzgerald raised its price target on Horizon Pharma (NASDAQ: HZNP) to $17.00 (from $13.00) while maintaining a Overweight rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
